Brief: Newron Pharmaceuticals FY net loss shrinks to EUR 15.2 mln

Newron Pharmaceuticals SpA

02/03/2017 06:00

March 2 (Reuters) - Newron Pharmaceuticals Spa  NWRN.S : 
    * Total revenues have substantially increased to 6.7 million 
euros  ($7.06 million) from 2.4 million euros in 2015 in the 
reporting period 
    * Says FY cash used in operations has increased to 19.6 
million euros (2015: 12.9 million euros) 
    * FY net loss at 15.2 million euros versus 22.8 million 
euros year ago 
 
Source text for Eikon:  ID:nTENoghfja  
     
Further company coverage:  NWRN.S  
 
($1 = 0.9496 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))